Ultime notizie per Westlake (NYSE:WLK) Azioni

WESTLAKE CORP

Westlake

Westlake Corp is a manufacturer and supplier of chemicals, polymers, and building products. Its Performance and Essential Materials segment offers a wide range of essential building blocks for making products utilized in everyday living, including olefins, vinyl chemicals, polyethylene, and epoxies. Its Housing and Infrastructure Products segment produces key finished goods for building products, pipe and fittings, and global compounds businesses.

Earnings

News

Pre-Market Outlook

Markets

Trading Ideas

Analisi dei titoli che potrebbero dominare la giornata finanziaria, tra opportunità nascoste e strategie vincenti per il tuo portafoglio.

Owens Corning, Domino&#39;s Pizza e altre 3 azioni da tenere d&#39;occhio oggi

Long Ideas

Ecco cosa osservano gli analisti e quali potrebbero essere le opportunità per gli investitori questo mese.

Scopri i 3 titoli del settore dei materiali che potrebbero esplodere questo mese

Westlake Corp

WALKABOUT RES LTD by Walkabout Resource Limited

Westlake Chemical Partners LP Common Units representing limited partner interests

Westlake Chemical Partners LP

WILK TECHNOLOGIES LTD by WILK TECHNOLOGIES LTD.

Wilk Technologies Ltd

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>D. Boral Capital cut Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVPH#NASDAQ">RVPH</a>) price target from $8 to $3. D. Boral Capital analyst Jason Kolbert maintained a Buy rating. Reviva Pharmaceuticals shares closed at $0.8900 on Monday. <a href="https://www.benzinga.com/quote/RVPH/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Jefferies raised the price target for ZIM Integrated Shipping Services Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIM#NYSE">ZIM</a>) from $16 to $17. Jefferies analyst Omar Nokta maintained a Hold rating. ZIM Integrated Shipping shares closed at $19.37 on Monday.<a href="https://www.benzinga.com/quote/ZIM/analyst-ratings"> See how other analysts view this stock.</a></li>
<li>Loop Capital cut MongoDB, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>) price target from $350 to $190. Loop Capital analyst Yun Kim downgraded the stock from Buy to Hold. MongoDB shares closed at $189.01 on Monday. See how other <a href="https://www.benzinga.com/quote/MDB/analyst-ratings">analysts view this stock</a>.</li>
<li>Citigroup raised the price target for Air Lease Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AL#NYSE">AL</a>) from $45 to $68. Citigroup analyst Kevin Crissey upgraded the stock from Neutral to Buy. Air Lease shares closed at $57.14 on Monday. <a href="https://www.benzinga.com/quote/AL/analyst-ratings">See how other analysts view this stock.</a></li>
<li>UBS slashed the price target for Mettler-Toledo International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTD#NYSE">MTD</a>) from $1,530 to $1,350. UBS analyst Dan Leonard upgraded the stock from Neutral to Buy. Mettler-Toledo International shares closed at $1,159.10 on Monday. <a href="https://www.benzinga.com/quote/MTD/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Wells Fargo cut Westlake Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) price target from $95 to $76. Wells Fargo analyst Michael Sison downgraded the stock from Overweight to Equal-Weight. Westlake shares settled at $79.94 on Monday. <a href="https://www.benzinga.com/quote/WLK/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Canaccord Genuity raised Spotify Technology S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>) price target from $700 to $775. Canaccord Genuity analyst Maria Ripps maintained a Buy rating. Spotify shares closed at $664.62 on Monday. <a href="https://www.benzinga.com/quote/SPOT/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Barclays boosted Urban Outfitters, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/URBN#NASDAQ">URBN</a>) price target from $59 to $73. Barclays analyst Adrienne Yih maintained an Overweight rating. Urban Outfitters shares closed at $61.42 on Monday.  <a href="https://www.benzinga.com/quote/URBN/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Keybanc increased the price target for Ollie&#8217;s Bargain Outlet Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLLI#NASDAQ">OLLI</a>) from $125 to $135. Keybanc analyst Bradley Thomas maintained an Overweight rating. Ollie&#8217;s Bargain Outlet shares settled at $120.75 on Monday. <a href="https://www.benzinga.com/quote/OLLI/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Baird raised JPMorgan Chase &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) price target from $220 to $235. Baird analyst David George maintained a Neutral rating. JPMorgan shares closed at $264.88 on Monday. <a href="https://www.benzinga.com/quote/JPM/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying SPOT stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="598" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/20090508/image-249-1024x598.png" alt="" class="wp-image-921252" style="width:608px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/20090508/image-249-1024x598.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/20090508/image-249-300x175.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/20090508/image-249-768x449.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/20090508/image-249.png 1116w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/earnings/25/05/45511338/home-depot-toll-brothers-and-3-stocks-to-watch-heading-into-tuesday">Home Depot, Toll Brothers And 3 Stocks To Watch Heading Into Tuesday</a> </li>
</ul>
Photo via Shutterstock

Price Target

Analyst Ratings

OLLI

RVPH

SPOT

URBN

Spotify To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Tuesday

BMO Capital analyst John McNulty maintains Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) with a Market Perform and lowers the price target from $103 to $94.

BMO Capital Maintains Market Perform on Westlake, Lowers Price Target to $94

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>Keybanc analyst Philip Gibbs downgraded the rating for ATI Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATI#NYSE">ATI</a>) from Overweight to Sector Weight. ATI shares closed at $76.58 on Monday. <a href="https://www.benzinga.com/quote/ATI/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>HC Wainwright &amp; Co. analyst Arthur He downgraded Prime Medicine, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRME#NASDAQ">PRME</a>) from Buy to Neutral. Prime Medicine shares closed at $1.3350 on Monday. <a href="https://www.benzinga.com/quote/PRME/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Loop Capital analyst Yun Kim downgraded MongoDB, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>) from Buy to Hold and lowered the price target from $350 to $190. MongoDB shares closed at $189.01 on Monday. <a href="https://www.benzinga.com/quote/AFRMDBM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan analyst Eric Joseph downgraded the rating for Prime Medicine, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRME#NASDAQ">PRME</a>) from Overweight to Neutral. Prime Medicine shares closed at $1.3350 on Monday. <a href="https://www.benzinga.com/quote/PRME/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wells Fargo analyst Michael Sison downgraded the rating for Westlake Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) from Overweight to Equal-Weight and cut the price target from $95 to $76. Westlake shares closed at $79.94 on Monday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratingsWLK">See how other analysts view this stock.</a></li>
</ul>
Considering buying MDB stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="563" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/20083003/image-246-1024x563.png" alt="" class="wp-image-921180" style="width:670px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/20083003/image-246-1024x563.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/20083003/image-246-300x165.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/20083003/image-246-768x422.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/20083003/image-246.png 1123w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/earnings/25/05/45511338/home-depot-toll-brothers-and-3-stocks-to-watch-heading-into-tuesday">Home Depot, Toll Brothers And 3 Stocks To Watch Heading Into Tuesday</a> </li>
</ul>
Photo via Shutterstock

Downgrades

PRME

This MongoDB Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) underwent analysis by 26 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">7</td>
<td align="right">7</td>
<td align="right">12</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">5</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $114.38, a high estimate of $166.00, and a low estimate of $76.00. This current average has decreased by 14.74% from the previous average price target of $134.15. 
<img src="https://www.benzinga.com/files/images/story/2025/1747742438_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
A clear picture of Westlake's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$76.00</td>
<td>$95.00</td>
</tr>
<tr>
<td>Charles Neivert</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$100.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Neel Kumar</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$98.00</td>
<td>$122.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$96.00</td>
<td>$122.00</td>
</tr>
<tr>
<td>Duffy Fischer</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$95.00</td>
<td>$130.00</td>
</tr>
<tr>
<td>Jeffrey Zekauskas</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$82.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>John McNulty</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$103.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$95.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>Michael Leithead</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$100.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Peter Osterland</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$117.00</td>
<td>$132.00</td>
</tr>
<tr>
<td>Steve Byrne</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$103.00</td>
<td>$116.00</td>
</tr>
<tr>
<td>Peter Osterland</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$132.00</td>
<td>$155.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$110.00</td>
<td>$130.00</td>
</tr>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$127.00</td>
<td>$144.00</td>
</tr>
<tr>
<td>Charles Neivert</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$105.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Patrick Cunningham</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$116.00</td>
<td>$130.00</td>
</tr>
<tr>
<td>Peter Osterland</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$155.00</td>
<td>$166.00</td>
</tr>
<tr>
<td>Charles Neivert</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$120.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Jeffrey Zekauskas</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$110.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$133.00</td>
<td>$147.00</td>
</tr>
<tr>
<td>Neel Kumar</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$122.00</td>
<td>$130.00</td>
</tr>
<tr>
<td>John McNulty</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$132.00</td>
<td>$157.00</td>
</tr>
<tr>
<td>Peter Osterland</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$166.00</td>
<td>$168.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$130.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>Steve Byrne</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$116.00</td>
<td>$134.00</td>
</tr>
<tr>
<td>Michael Leithead</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$135.00</td>
<td>$175.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Westlake. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Westlake compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Westlake's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of Westlake's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/WLK/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Westlake analyst ratings.</a>
<h2>Get to Know Westlake Better</h2>
Westlake Corp is a manufacturer and supplier of chemicals, polymers, and building products. Its Performance and Essential Materials segment offers a wide range of essential building blocks for making products utilized in everyday living, including olefins, vinyl chemicals, polyethylene, and epoxies. Its Housing and Infrastructure Products segment produces key finished goods for building products, pipe and fittings, and global compounds businesses.
<h3>Westlake: A Financial Overview</h3>
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
Revenue Challenges: Westlake's revenue growth over 3M faced difficulties. As of 31 March, 2025, the company experienced a decline of approximately -4.34%. This indicates a decrease in top-line earnings. When compared to others in the Materials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Westlake's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -1.41% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Westlake's ROE excels beyond industry benchmarks, reaching -0.38%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Westlake's ROA excels beyond industry benchmarks, reaching -0.19%. This signifies efficient management of assets and strong financial health.
Debt Management: With a below-average debt-to-equity ratio of 0.53, Westlake adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Basics of Analyst Ratings</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Deep Dive Into Westlake Stock: Analyst Perspectives (26 Ratings)

Wells Fargo analyst Michael Sison downgrades Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) from Overweight to Equal-Weight and lowers the price target from $95 to $76.

Wells Fargo Downgrades Westlake to Equal-Weight, Lowers Price Target to $76

Piper Sandler analyst Charles Neivert maintains Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) with a Neutral and lowers the price target from $105 to $100.

Piper Sandler Maintains Neutral on Westlake, Lowers Price Target to $100

WIIM

AVNT

AXTA

CENX

MATV

MEOH

MTUS

PACK

TANH

TROX

Shares of companies within the broader materials sector are trading higher amid overall market strength after the US and China agreed to a temporary reduction in most tariffs on each other's goods. A decrease of trade tensions could reduce demand uncertainty for materials.

Morgan Stanley analyst Neel Kumar maintains Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) with a Equal-Weight and lowers the price target from $122 to $98.

Morgan Stanley Maintains Equal-Weight on Westlake, Lowers Price Target to $98

RBC Capital analyst Arun Viswanathan maintains Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) with a Outperform and lowers the price target from $122 to $96.

RBC Capital Maintains Outperform on Westlake, Lowers Price Target to $96

Goldman Sachs analyst Duffy Fischer maintains Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) with a Neutral and lowers the price target from $130 to $95.

Goldman Sachs Maintains Neutral on Westlake, Lowers Price Target to $95

JP Morgan analyst Jeffrey Zekauskas maintains Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) with a Neutral and lowers the price target from $110 to $82.

JP Morgan Maintains Neutral on Westlake, Lowers Price Target to $82

BMO Capital analyst John McNulty maintains Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) with a Market Perform and lowers the price target from $125 to $103.

BMO Capital Maintains Market Perform on Westlake, Lowers Price Target to $103

Wells Fargo analyst Michael Sison maintains Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) with a Overweight and lowers the price target from $110 to $95.

Wells Fargo Maintains Overweight on Westlake, Lowers Price Target to $95

Barclays analyst Michael Leithead maintains Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) with a Overweight and lowers the price target from $135 to $100.

Barclays Maintains Overweight on Westlake, Lowers Price Target to $100

Truist Securities analyst Peter Osterland maintains Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) with a Buy and lowers the price target from $132 to $117.

Truist Securities Maintains Buy on Westlake, Lowers Price Target to $117

These large-cap stocks were the worst performers in the last week. Are they in your portfolio?
<ol>
<li>Block, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYZ#NYSE">XYZ</a>) shares tumbled 19.90% after the company reported <a href="https://www.benzinga.com//node/45152696" target="_blank" rel="noreferrer noopener">worse-than-expected financial results</a>. Analysts slashed <a href="https://www.benzinga.com/quote/xyz/analyst-ratings" target="_blank" rel="noreferrer noopener">the price forecast on the stock</a>.</li>
<li>Lineage, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LINE#NASDAQ">LINE</a>) shares fell 18.93% after reporting worse-than-expected <a href="https://www.benzinga.com//node/45093641" target="_blank" rel="noreferrer noopener">first-quarter sales results</a>. Some analysts lowered the <a href="https://www.benzinga.com/quote/line/analyst-ratings" target="_blank" rel="noreferrer noopener">price forecast on the stock</a>.</li>
<li>Becton, Dickinson and Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BDX#NYSE">BDX</a>) stock dipped 17.70%  after the company cut FY25 EPS guidance despite a hike in sales outlook. The company also missed <a href="https://www.benzinga.com//node/45140102" target="_blank" rel="noreferrer noopener">second-quarter revenue estimates</a>. Analysts cut <a href="https://www.benzinga.com/quote/bdx/analyst-ratings" target="_blank" rel="noreferrer noopener">the price forecast on the stock</a>.</li>
<li>Coca-Cola (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COKE#NASDAQ">COKE</a>) shares decreased 16.36%  after the company reported a year-over-year decrease in <a href="https://www.benzinga.com//node/45116927" target="_blank" rel="noreferrer noopener">first-quarter financial results</a>.</li>
<li>Westlake Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) stock fell 14.50% after the company reported worse-than-expected <a href="https://www.benzinga.com//node/45161312" target="_blank" rel="noreferrer noopener">first-quarter sales results</a>.</li>
<li>Pilgrim&#8217;s Pride Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PPC#NASDAQ">PPC</a>) stock dived 13.84% after the company reported worse-than-expected <a href="https://www.benzinga.com//node/45118399" target="_blank" rel="noreferrer noopener">first-quarter financial results</a>.</li>
<li>Ecopetrol S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EC#NYSE">EC</a>) shares declined 12.27% probably amid a drop in oil and natural gas prices following a decline in U.S. first-quarter GDP, which could weigh on demand outlook.</li>
<li>Alamos Gold Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGI#NYSE">AGI</a>) shares were down 11.59% after the company reported <a href="https://www.benzinga.com//node/45119634" target="_blank" rel="noreferrer noopener">first-quarter results below estimates</a>. The stock may also be down amid a drop in gold spot price.</li>
<li>YPF Sociedad Anonima (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YPF#NYSE">YPF</a>) stock fell 9.09%.</li>
<li>Targa Resources, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRGP#NYSE">TRGP</a>) stock dived 8.87% after the company reported <a href="https://www.benzinga.com//node/45128247" target="_blank" rel="noreferrer noopener">earnings for the first quarter</a>.</li>
</ol>
Photo via Shutterstock

Equities

Large Cap

Movers

COKE

FSLR

LINE

TRGP

Block, Becton Dickinson And Pilgrim's Pride Are Among Top 10 Large-Cap Losers Last Week (Apr 28-May 2): Are The Others In Your Portfolio?

Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $0.68 by 145.59 percent. This is a 123.13 percent decrease over earnings of $1.34 per share from the same period last year. The company reported quarterly sales of $2.85 billion which missed the analyst consensus estimate of $2.95 billion by 3.52 percent. This is a 4.34 percent decrease over sales of $2.98 billion the same period last year.

Earnings Misses

Westlake Q1 EPS $(0.31) Misses $0.68 Estimate, Sales $2.85B Miss $2.95B Estimate

<h3>Companies Reporting Before The Bell</h3>
• Franklin Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEN#NYSE">BEN</a>) is estimated to report quarterly earnings at $0.47 per share on revenue of $1.98 billion. 
• Arbor Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABR#NYSE">ABR</a>) is estimated to report quarterly earnings at $0.29 per share on revenue of $79.89 million. 
• American Axle &amp; Mfg Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXL#NYSE">AXL</a>) is expected to report quarterly earnings at $0.06 per share on revenue of $1.43 billion. 
• Liberty Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LBTYA#NASDAQ">LBTYA</a>) is expected to report quarterly loss at $0.83 per share on revenue of $1.08 billion. 
• Madison Square Garden (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSGS#NYSE">MSGS</a>) is expected to report quarterly earnings at $1.30 per share on revenue of $427.39 million. 
• United States Cellular (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USM#NYSE">USM</a>) is estimated to report quarterly earnings at $0.37 per share on revenue of $925.42 million. 
• Telephone and Data Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDS#NYSE">TDS</a>) is likely to report quarterly loss at $0.02 per share on revenue of $1.19 billion. 
• FuboTV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUBO#NYSE">FUBO</a>) is likely to report quarterly loss at $0.03 per share on revenue of $415.45 million. 
• Terex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEX#NYSE">TEX</a>) is estimated to report quarterly earnings at $0.57 per share on revenue of $1.25 billion. 
• WisdomTree (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WT#NYSE">WT</a>) is projected to report quarterly earnings at $0.15 per share on revenue of $108.98 million. 
• Criteo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRTO#NASDAQ">CRTO</a>) is likely to report quarterly earnings at $0.77 per share on revenue of $260.12 million. 
• Wendy's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WEN#NASDAQ">WEN</a>) is likely to report quarterly earnings at $0.20 per share on revenue of $526.63 million. 
• Brookfield Renewable (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEP#NYSE">BEP</a>) is estimated to report quarterly loss at $0.40 per share on revenue of $1.70 billion. 
• Brookfield Renewable (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEPC#NYSE">BEPC</a>) is likely to report quarterly loss at $0.25 per share on revenue of $2.16 billion. 
• SES AI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SES#NYSE">SES</a>) is likely to report quarterly earnings at $0.26 per share on revenue of $351.00 million. 
• Fulgent Genetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLGT#NASDAQ">FLGT</a>) is projected to report quarterly loss at $0.18 per share on revenue of $71.26 million. 
• Perella Weinberg (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PWP#NASDAQ">PWP</a>) is projected to report quarterly earnings at $0.21 per share on revenue of $205.52 million. 
• Fluor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>) is likely to report quarterly earnings at $0.50 per share on revenue of $4.18 billion. 
• Brookfield Bus Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBU#NYSE">BBU</a>) is expected to report earnings for its first quarter. 
• Atmus Filtration Techs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATMU#NYSE">ATMU</a>) is likely to report quarterly earnings at $0.59 per share on revenue of $421.40 million. 
• nVent Electric (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVT#NYSE">NVT</a>) is expected to report quarterly earnings at $0.66 per share on revenue of $790.29 million. 
• Cinemark Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNK#NYSE">CNK</a>) is projected to report quarterly loss at $0.25 per share on revenue of $522.45 million. 
• Westlake Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLKP#NYSE">WLKP</a>) is expected to report quarterly earnings at $0.38 per share on revenue of $295.59 million. 
• Xenia Hotels &amp; Resorts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XHR#NYSE">XHR</a>) is likely to report quarterly earnings at $0.42 per share on revenue of $273.46 million. 
• AirSculpt Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRS#NASDAQ">AIRS</a>) is estimated to report quarterly loss at $0.03 per share on revenue of $39.25 million. 
• City Office REIT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIO#NYSE">CIO</a>) is expected to report quarterly earnings at $0.28 per share on revenue of $42.20 million. 
• Johnson Outdoors (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JOUT#NASDAQ">JOUT</a>) is expected to report quarterly earnings at $0.21 per share on revenue of $168.05 million. 
• AES (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AES#NYSE">AES</a>) is estimated to report quarterly earnings at $0.46 per share on revenue of $3.10 billion. 
• Patria Investments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAX#NASDAQ">PAX</a>) is projected to report quarterly earnings at $0.25 per share on revenue of $85.63 million. 
• Cboe Global Markets (BATS:<a class="ticker" href="https://www.benzinga.com/stock/CBOE#BATS">CBOE</a>) is likely to report quarterly earnings at $2.36 per share on revenue of $559.99 million. 
• T. Rowe Price Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TROW#NASDAQ">TROW</a>) is projected to report quarterly earnings at $2.13 per share on revenue of $1.78 billion. 
• Eaton Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETN#NYSE">ETN</a>) is estimated to report quarterly earnings at $2.71 per share on revenue of $6.25 billion. 
• Apollo Global Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APO#NYSE">APO</a>) is projected to report quarterly earnings at $1.96 per share on revenue of $4.64 billion. 
• Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) is projected to report quarterly earnings at $0.65 per share on revenue of $2.95 billion. 
• Chevron (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>) is likely to report quarterly earnings at $2.18 per share on revenue of $48.08 billion. 
• MISTRAS Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MG#NYSE">MG</a>) is projected to report quarterly earnings at $0.90 per share on revenue of $9.68 billion. 
• ING Groep (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ING#NYSE">ING</a>) is estimated to report earnings for its first quarter. 
• Shell (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHEL#NYSE">SHEL</a>) is expected to report quarterly earnings at $1.65 per share on revenue of $79.13 billion. 
• IES Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IESC#NASDAQ">IESC</a>) is projected to report earnings for its second quarter. 
• Magna International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MGA#NYSE">MGA</a>) is likely to report quarterly earnings at $0.86 per share on revenue of $9.73 billion. 
• Piper Sandler (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PIPR#NYSE">PIPR</a>) is likely to report quarterly earnings at $2.85 per share on revenue of $367.73 million. 
• Proto Labs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRLB#NYSE">PRLB</a>) is likely to report quarterly earnings at $0.29 per share on revenue of $123.71 million. 
• Cigna Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CI#NYSE">CI</a>) is estimated to report quarterly earnings at $6.35 per share on revenue of $60.39 billion. 
• BrightSpring Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTSG#NASDAQ">BTSG</a>) is estimated to report quarterly earnings at $0.09 per share on revenue of $2.74 billion. 
• Amneal Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMRX#NASDAQ">AMRX</a>) is estimated to report quarterly earnings at $0.15 per share on revenue of $715.49 million. 
• DuPont de Nemours (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DD#NYSE">DD</a>) is projected to report quarterly earnings at $0.95 per share on revenue of $3.04 billion. 
• inTest (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/INTT#AMEX">INTT</a>) is likely to report quarterly loss at $0.10 per share on revenue of $28.07 million. 
• Butterfly Network (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BFLY#NYSE">BFLY</a>) is projected to report quarterly loss at $0.07 per share on revenue of $21.16 million. 
• Interface (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TILE#NASDAQ">TILE</a>) is estimated to report quarterly earnings at $0.21 per share on revenue of $297.11 million. 
• Vince Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VNCE#NYSE">VNCE</a>) is projected to report quarterly loss at $0.09 per share on revenue of $72.98 million. 
• NatWest Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NWG#NYSE">NWG</a>) is expected to report earnings for its first quarter. 
• AdvanSix (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASIX#NYSE">ASIX</a>) is projected to report quarterly earnings at $0.82 per share on revenue of $347.25 million. 
• Exxon Mobil (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>) is expected to report quarterly earnings at $1.70 per share on revenue of $86.09 billion. 
• Brookfield Business (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBUC#NYSE">BBUC</a>) is estimated to report earnings for its first quarter. 
<h3>Companies Reporting After The Bell</h3>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AIRS

AMRX

ASIX

ATMU

BBUC

BEPC

BFLY

BTSG

CBOE

CRTO

FLGT

FUBO

IESC

INTT

JOUT

LBTYA

MSGS

PIPR

PRLB

PowerShares Exchange Traded Fund Trust Dynamic Mid Cap Value Portfolio

SHEL

TILE

TROW

VNCE

WLKP

Earnings Scheduled For May 2, 2025

Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) is gearing up to announce its quarterly earnings on Friday, 2025-05-02. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Westlake will report an earnings per share (EPS) of $0.96.
Anticipation surrounds Westlake's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Earnings History Snapshot</h3>
The company's EPS missed by $1.03 in the last quarter, leading to a 2.34% increase in the share price on the following day.
Here's a look at Westlake's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.09</td>
<td>2.20</td>
<td>1.99</td>
<td>1.02</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.06</td>
<td>1.41</td>
<td>2.40</td>
<td>1.34</td>
</tr>
<tr>
<td>Price Change %</td>
<td>2.0%</td>
<td>3.0%</td>
<td>-0.0%</td>
<td>0.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1746108102_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Westlake were trading at $92.43 as of April 30. Over the last 52-week period, shares are down 39.2%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<h3>Analyst Insights on Westlake</h3>
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Westlake.
The consensus rating for Westlake is Buy, based on 16 analyst ratings. With an average one-year price target of $125.75, there's a potential 36.05% upside.
<h3>Peer Ratings Overview</h3>
The below comparison of the analyst ratings and average 1-year price targets of Cabot, Hawkins and Olin, three prominent players in the industry, gives insights for their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Neutral trajectory for Cabot, with an average 1-year price target of $84.0, suggesting a potential 9.12% downside.</li>
<li>Analysts currently favor an Buy trajectory for Hawkins, with an average 1-year price target of $141.0, suggesting a potential 52.55% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Olin, with an average 1-year price target of $29.56, suggesting a potential 68.02% downside.</li>
</ul>
<h3>Peers Comparative Analysis Summary</h3>
The peer analysis summary offers a detailed examination of key metrics for Cabot, Hawkins and Olin, providing valuable insights into their respective standings within the industry and their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Westlake</td>
<td>Buy</td>
<td>0.60%</td>
<td>$328M</td>
<td>0.07%</td>
</tr>
<tr>
<td>Cabot</td>
<td>Neutral</td>
<td>-0.31%</td>
<td>$235M</td>
<td>6.59%</td>
</tr>
<tr>
<td>Hawkins</td>
<td>Buy</td>
<td>8.49%</td>
<td>$48.42M</td>
<td>3.34%</td>
</tr>
<tr>
<td>Olin</td>
<td>Neutral</td>
<td>3.51%</td>
<td>$157.90M</td>
<td>0.52%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Westlake ranks at the top for Revenue Growth with 0.60%. It is in the middle for Gross Profit at $328M. Westlake is at the bottom for Return on Equity with 0.07%.
<h3>Discovering Westlake: A Closer Look</h3>
Westlake Corp is a manufacturer and supplier of chemicals, polymers, and building products. Its Performance and Essential Materials segment offers a wide range of essential building blocks for making products utilized in everyday living, including olefins, vinyl chemicals, polyethylene, and epoxies. Its Housing and Infrastructure Products segment produces key finished goods for building products, pipe and fittings, and global compounds businesses.
<h3>Understanding the Numbers: Westlake's Finances</h3>
Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.
Revenue Growth: Over the 3 months period, Westlake showcased positive performance, achieving a revenue growth rate of 0.6% as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Materials sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Westlake's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 0.25%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Westlake's ROE stands out, surpassing industry averages. With an impressive ROE of 0.07%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Westlake's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 0.03%, the company showcases efficient use of assets and strong financial health.
Debt Management: Westlake's debt-to-equity ratio is below the industry average. With a ratio of 0.5, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<a href="https://www.benzinga.com/quote/WLK/earnings">To track all earnings releases for Westlake visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Peek at Westlake's Future Earnings

Westlake's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) short percent of float has risen 17.37% since its last report. The company recently reported that it has 3.16 million shares sold short, which is 9.46% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.41 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Westlake Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746039622_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Westlake has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Westlake's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Westlake's peer group average for short interest as a percentage of float is 5.93%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Comments

Westlake

Notizie

Ultime notizie per Westlake (NYSE:WLK) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO